Actively Recruiting

Age: 18Years +
All Genders
NCT06687408

Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2026-04-24

450

Participants Needed

3

Research Sites

147 weeks

Total Duration

On this page

Sponsors

S

Second Affiliated Hospital, School of Medicine, Zhejiang University

Lead Sponsor

S

Shanghai Chest Hospital of Shanghai Jiao Tong University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this multicenter observational study is to evaluate the long-term survival and perioperative outcomes of sleeve lobectomy in robotic-assisted thoracic surgery (RATS) for patients with central lung cancer when compared with video-assisted thoracic surgery (VATS) approach, both of which have been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently. The main question it aims to answer is: Are RATS sleeve lobectomy associated with similar or even better long-term survival and perioperative outcomes for patients with central lung cancer when compared with the VATS approach?

CONDITIONS

Official Title

Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age �3E= 18 years
  • Clinically suspected lung cancer with a high likelihood of undergoing sleeve lobectomy
  • Postoperative diagnosis confirms non-small cell lung cancer (NSCLC)
  • No history of malignancy within the past 5 years
  • Signed informed consent agreeing to participate in the study
Not Eligible

You will not qualify if you...

  • Unable to undergo surgical resection due to contraindications
  • Postoperative pathology does not confirm NSCLC, including benign lesions, small cell lung cancer, metastatic tumors, or insufficient histopathology
  • History of malignancy within the past 5 years
  • Unable to obtain follow-up data
  • Refusal or withdrawal of informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, China, 310009

Actively Recruiting

2

Sir Run Run Shaw Hospital, Medical College, Zhejiang University

Hangzhou, China, 310016

Actively Recruiting

3

Shanghai Chest Hospital, Shanghai Jiao Tong University

Shanghai, China, 200030

Actively Recruiting

Loading map...

Research Team

H

Haifeng Shen, M.D.

CONTACT

J

Junqiang Fan, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here